The diabetes follow-up was routine until the ultrasound report added one more line: “fatty liver”. Or it went the other way: a scan showed fatty liver, and the next blood test called the sugar “borderline”. In India the two often turn up together. A review of 18 Indian studies covering 81,364 adults with type 2 diabetes found fatty liver in 56.9% of them, with single studies ranging from 34% to 94%.
This guide explains why the two travel together, why diabetes makes a fatty liver more likely to scar, which tests separate low risk from high risk, and what helps both at once.
Key Takeaways
- More than half of Indian adults with type 2 diabetes have fatty liver.
- The shared root is insulin resistance, and the link runs both ways.
- Diabetes raises the chance of liver scarring, often while liver enzymes stay normal.
- US diabetes standards (ADA 2026) advise a FIB-4 score for adults with type 2 diabetes, then FibroScan if it is 1.3 or more.
- Weight loss, activity and fewer refined carbohydrates help sugar and liver together; liver tonics do not.
What links fatty liver and diabetes
Definition: Fatty liver disease (also called NAFLD, now renamed MASLD) means extra fat stored in the liver, linked with weight, blood sugar, blood pressure or cholesterol rather than alcohol. Insulin resistance means the body responds poorly to insulin, the hormone that moves sugar out of the blood, so the pancreas must make more of it.
Fatty liver is usually silent. Indian guidance (INASL, 2023) notes that most cases are found by chance on a scan or blood test, or cause only vague complaints until the disease is advanced, so the symptoms of fatty liver disease are an unreliable guide for someone with diabetes.
What joins the two is insulin resistance. The American Diabetes Association (ADA) calls it the main driver of fat building up in the liver, with excess belly fat a key contributor. American liver guidance (AASLD, 2023) adds that fatty liver lowers the response to insulin even before diabetes appears, and that as liver disease advances, diabetes becomes harder to control. Each condition feeds the other.
Does fatty liver cause diabetes, or the other way round?
Both, says AASLD. Diabetes makes fatty liver more likely, and fatty liver is linked with a 2- to 5-fold higher risk of developing diabetes, so people with fatty liver should have their sugar checked. By the ADA definition, an HbA1c (average blood sugar over the past 2-3 months) of 5.7-6.4% is prediabetes, the usual “borderline sugar”, and 6.5% or more on repeat testing is diabetes.
Why diabetes makes fatty liver more serious
Fat alone is usually not the danger. The concern is inflammation (MASH, earlier NASH) and scarring (fibrosis), which can progress over years to cirrhosis. AASLD calls type 2 diabetes the most impactful risk factor for scarring getting worse and for liver cancer, and notes that the chance of advanced scarring rises with the years of diabetes.
- The ADA estimates that inflammation is present in more than half of people with type 2 diabetes who have fatty liver.
- In a Mumbai study of 1,521 people with type 2 diabetes, included in the Indian review above, more than a quarter had scarring on FibroScan.
- The ADA notes that scarring often sits with SGPT (ALT) and SGOT (AST) below the usual 40 units/L cut-off, so enzyme-based screening misses most people with MASH.
Fibrosis screening in type 2 diabetes: FIB-4 first, then FibroScan
The ADA Standards of Care in Diabetes 2026 advise screening adults with type 2 diabetes or prediabetes, especially with obesity or heart risk factors, using a FIB-4 score, even if liver enzymes are normal, to catch scarring before cirrhosis or liver cancer. INASL likewise recommends FIB-4 first in Indian primary care.
FIB-4 needs no extra sample: it is calculated from age, SGOT, SGPT and platelet count. It is not validated under 35, and from 65 a cut-off of 1.9-2.0 applies. A score of 1.3 or more leads to a FibroScan (transient elastography) stiffness reading.
What to check when you have both
| Test | What it tells you | How to read it (ADA 2026) |
|---|---|---|
| HbA1c | Average sugar, past 2-3 months | 5.7-6.4% prediabetes; 6.5% or more, confirmed, diabetes |
| SGPT (ALT), SGOT (AST) | Liver cell irritation | Normal values do not rule out scarring |
| FIB-4 score | Risk of advanced scarring | Below 1.3 lower risk; 1.3 or more needs FibroScan; above 2.67 high risk |
| FibroScan | Scarring as stiffness in kPa (kilopascals); fat as CAP (controlled attenuation parameter) | Below 8.0 kPa lower risk, repeat in 2 years or more; 8.0 or more, specialist review |
| Lipid profile | Cholesterol, triglycerides | Guides heart-risk treatment |
Lipids matter because heart disease, not liver disease, is the main cause of death in type 2 diabetes with fatty liver, the ADA notes.
What helps both fatty liver and diabetes
- Food pattern. The Indian diet chart for fatty liver sets out daily meals. The principle, from the ADA, is less saturated fat, refined carbohydrate and added sugar: smaller rice and roti portions, fewer maida and fried items, no sugar in chai, more dal, sabzi and salad, and mithai kept for occasions.
- Weight loss. The ADA sets a minimum of 5% of body weight, preferably 10% or more, to improve the liver, with scarring needing the larger loss; for an 80 kg adult that is 4 to 8 kg. It also helps sugar and heart.
- Activity. INASL advises 30-45 minutes of moderate exercise, such as brisk walking or cycling, at least five days a week. Exercise can reduce liver fat even when the scale does not move.
Medicines that can help both: your doctor decides
The treating doctor chooses, based on sugar level, weight, heart and kidney health, scarring stage and cost.
- GLP-1 based medicines. For type 2 diabetes with a high scarring risk, ADA 2026 prefers a GLP-1 receptor agonist for sugar control because of its benefit in MASH. Semaglutide is the only diabetes or weight medicine approved by the US FDA for MASH; tirzepatide, a dual GIP and GLP-1 medicine, can also be considered.
- Pioglitazone. Can be considered, says the ADA, with trade-offs: weight gain, fracture risk and caution in heart failure.
- Saroglitazar. Approved in India by the DCGI in March 2020 for MASH with F1-F3 scarring, according to INASL.
- Metformin and most other sugar medicines. These continue as needed, but the ADA and INASL note they do not improve the liver under the microscope.
- Statins. INASL says statins, when needed, are safe in fatty liver even with raised liver enzymes.
What not to do
- Do not stop diabetes medicines because a report mentions fatty liver. The ADA advises continuing them as clinically indicated.
- Do not rely on liver tonics. AASLD advises that UDCA (ursodeoxycholic acid) and silymarin (milk thistle extract), found in many “liver protector” products, should not be used to treat MASH because they show no meaningful benefit.
- Do not read a normal SGPT as an all-clear. Ask for the FIB-4 score.
What’s changing
Liver scarring checks are now part of the ADA’s routine diabetes standards, and INASL notes that India’s national programme for non-communicable diseases (NPCDCS) has added fatty liver. In the semaglutide trial behind the US approval, scarring improved at 72 weeks in 36.8% on the drug against 22.4% on placebo.
Conclusion
Fatty liver and type 2 diabetes share a root in insulin resistance, and each raises the risk of the other. With diabetes, the useful question is not “is there fat?” but “is there scarring?” A FIB-4 score, then FibroScan when needed, answers it, and the same weight loss, activity and medicine choices serve both.
Diabetes and fatty liver, checked together If you have type 2 diabetes and a scan has mentioned fatty liver, or fatty liver with a borderline sugar, the next step is to find out whether there is scarring. Dr Sushrut Singh, a gastroenterologist with a DM from ILBS, New Delhi, consults at Fortis Hospital, Sector 62, Noida, and at his clinic in Gaur City 2, Greater Noida West. Call or WhatsApp 093153 54431, and bring your HbA1c, liver function test, blood count, ultrasound and medicine list.
Frequently Asked Questions (FAQs)
Does fatty liver cause diabetes?
It raises the risk. AASLD links fatty liver with a 2- to 5-fold higher risk of developing diabetes, so an HbA1c test is sensible.
My SGPT is normal. Do I still need a liver check if I have diabetes?
Yes. The ADA advises a FIB-4 score even with normal liver enzymes, because scarring is often found with SGPT below 40 units/L.
Can I take metformin if I have fatty liver?
If prescribed for sugar, the ADA advises continuing it as clinically indicated, though it does not treat the liver. In cirrhosis with complications the ADA prefers insulin, so share every liver report.
Will controlling sugar alone clear a fatty liver?
Not reliably. AASLD calls the evidence on sugar control and liver progression unsettled; weight loss of 5-10% has clearer evidence.